RSPR Pharma is a privately-held clinical stage pharmaceutical company developing a novel oral non-steroidal anti-asthmatic for the treatment of patients with asthma that is not controlled by gold standard therapy with inhaled corticosteroids and long-acting beta-agonists (ICS/LABA). The company has a virtual set-up with a management team highly experienced in drug development. The company is based in Stockholm with clinical operations located in Copenhagen.
View Top Employees from RSPR Pharma AB| Website | http://www.rsprpharma.com |
| Revenue | $6 million |
| Employees | View employees |
| Phone | +46 70 975 98 63 |
| Industry | Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Pharmaceutical, Health Care |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular RSPR Pharma AB employee's phone or email?
RSPR Pharma AB Questions
The RSPR Pharma AB annual revenue was $6 million in 2023.
RSPR Pharma AB is based in Uppsala, Uppsala.
The NAICS codes for RSPR Pharma AB are [32, 3254, 325, 32541].
The SIC codes for RSPR Pharma AB are [283, 28].
